INS CD-BIOMARKER TESTING

Reinserts the provisions of the introduced bill with the following changes. In provisions concerning biomarker testing, removes provisions concerning requests for exceptions to restricted coverage; the publication of medical policies and coverage guidelines; written justifications for denial of coverage; prior authorization; and periodic audits and reviews. Provides that the biomarker testing requirements are subject to, and shall operate in accordance with, specified provisions of the Prior Authorization Reform Act and the Managed Care Reform and Patient Rights Act. Provides that the changes made by the amendatory Act apply to policies, contracts, and certificates of insurance amended, delivered, issued, or renewed on or after January 1, 2028. Makes other changes. Effective January 1, 2028.